Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 326

1.

Asxl2-/- Mice Exhibit De Novo Cardiomyocyte Production during Adulthood.

Brunner R, Lai HL, Deliu Z, Melman E, Geenen DL, Wang QT.

J Dev Biol. 2016 Nov 3;4(4). pii: E32. doi: 10.3390/jdb4040032.

2.

Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4-NKX2-5 Interaction.

Kinnunen SM, Tölli M, Välimäki MJ, Gao E, Szabo Z, Rysä J, Ferreira MPA, Ohukainen P, Serpi R, Correia A, Mäkilä E, Salonen J, Hirvonen J, Santos HA, Ruskoaho H.

Sci Rep. 2018 Mar 15;8(1):4611. doi: 10.1038/s41598-018-22830-8.

3.

Cardiac Progenitor Cells in Basic Biology and Regenerative Medicine.

Witman N, Sahara M.

Stem Cells Int. 2018 Feb 5;2018:8283648. doi: 10.1155/2018/8283648. eCollection 2018. Review.

4.

Direct conversion of human fibroblasts into functional Leydig-like cells by SF-1, GATA4 and NGFI-B.

Hou YP, Zhang ZY, Xing XY, Zhou J, Sun J.

Am J Transl Res. 2018 Jan 15;10(1):175-183. eCollection 2018.

5.

Cardiac stem cell trials and the new world of cellular reprogramming: Time to move on.

Rosengart TK, Patel V, Sellke FW.

J Thorac Cardiovasc Surg. 2018 Apr;155(4):1642-1646. doi: 10.1016/j.jtcvs.2017.11.104. Epub 2017 Dec 26. No abstract available.

6.

Nanotechnology-Based Cardiac Targeting and Direct Cardiac Reprogramming: The Betrothed.

Passaro F, Testa G, Ambrosone L, Costagliola C, Tocchetti CG, di Nezza F, Russo M, Pirozzi F, Abete P, Russo T, Bonaduce D.

Stem Cells Int. 2017;2017:4940397. doi: 10.1155/2017/4940397. Epub 2017 Dec 11. Review.

7.

High content analysis identifies unique morphological features of reprogrammed cardiomyocytes.

Sutcliffe MD, Tan PM, Fernandez-Perez A, Nam YJ, Munshi NV, Saucerman JJ.

Sci Rep. 2018 Jan 19;8(1):1258. doi: 10.1038/s41598-018-19539-z.

8.

Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types.

Cambria E, Pasqualini FS, Wolint P, Günter J, Steiger J, Bopp A, Hoerstrup SP, Emmert MY.

NPJ Regen Med. 2017 Jun 13;2:17. doi: 10.1038/s41536-017-0024-1. eCollection 2017. Review.

9.

Elixir of Life: Thwarting Aging With Regenerative Reprogramming.

Beyret E, Martinez Redondo P, Platero Luengo A, Izpisua Belmonte JC.

Circ Res. 2018 Jan 5;122(1):128-141. doi: 10.1161/CIRCRESAHA.117.311866. Review.

PMID:
29301845
10.

Resolution of organ fibrosis.

Jun JI, Lau LF.

J Clin Invest. 2018 Jan 2;128(1):97-107. doi: 10.1172/JCI93563. Epub 2018 Jan 2.

PMID:
29293097
11.

Pathophysiology and therapeutic potential of cardiac fibrosis.

Hara H, Takeda N, Komuro I.

Inflamm Regen. 2017 Jul 17;37:13. doi: 10.1186/s41232-017-0046-5. eCollection 2017. Review.

12.

Heart regeneration for clinical application update 2016: from induced pluripotent stem cells to direct cardiac reprogramming.

Yamakawa H.

Inflamm Regen. 2016 Oct 24;36:23. doi: 10.1186/s41232-016-0028-z. eCollection 2016. Review.

13.

Treatment of Myocardial Infarction with Gene-modified Mesenchymal Stem Cells in a Small Molecular Hydrogel.

Wu Z, Chen G, Zhang J, Hua Y, Li J, Liu B, Huang A, Li H, Chen M, Ou C.

Sci Rep. 2017 Nov 20;7(1):15826. doi: 10.1038/s41598-017-15870-z.

14.

Resident fibroblast expansion during cardiac growth and remodeling.

Ivey MJ, Kuwabara JT, Pai JT, Moore RE, Sun Z, Tallquist MD.

J Mol Cell Cardiol. 2018 Jan;114:161-174. doi: 10.1016/j.yjmcc.2017.11.012. Epub 2017 Nov 20.

PMID:
29158033
15.

Harnessing Epicardial Progenitor Cells and Their Derivatives for Rescue and Repair of Cardiac Tissue After Myocardial Infarction.

Rao KS, Spees JL.

Curr Mol Biol Rep. 2017 Sep;3(3):149-158. doi: 10.1007/s40610-017-0066-6. Epub 2017 Jul 15.

PMID:
29057207
16.

Alginate for cardiac regeneration: From seaweed to clinical trials.

Liberski A, Latif N, Raynaud C, Bollensdorff C, Yacoub M.

Glob Cardiol Sci Pract. 2016 Mar 31;2016(1):e201604. doi: 10.21542/gcsp.2016.4. Review.

17.

CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.

Zhu W, Zhao M, Mattapally S, Chen S, Zhang J.

Circ Res. 2018 Jan 5;122(1):88-96. doi: 10.1161/CIRCRESAHA.117.311504. Epub 2017 Oct 10.

PMID:
29018036
18.

ZNF281 enhances cardiac reprogramming by modulating cardiac and inflammatory gene expression.

Zhou H, Morales MG, Hashimoto H, Dickson ME, Song K, Ye W, Kim MS, Niederstrasser H, Wang Z, Chen B, Posner BA, Bassel-Duby R, Olson EN.

Genes Dev. 2017 Sep 1;31(17):1770-1783. doi: 10.1101/gad.305482.117.

19.

Approaches to augment vascularisation and regeneration of the adult heart via the reactivated epicardium.

Duffey OJ, Smart N.

Glob Cardiol Sci Pract. 2016 Dec 30;2016(4):e201628. doi: 10.21542/gcsp.2016.28. Review.

20.

A biomaterial approach to cell reprogramming and differentiation.

Long J, Kim H, Kim D, Lee JB, Kim DH.

J Mater Chem B. 2017 Apr 7;5(13):2375-2379. doi: 10.1039/C6TB03130G. Epub 2017 Feb 20.

Supplemental Content

Support Center